Cubosome-Based Nanoformulation Of Synthesized 1-Cyclopentyl Benzimidazole: In-Vitro Characterization And Antibacterial Evaluation

Read full text Summarise with VIRAT
Authors: Tanzeela Masood, Ikram Ullah Khan, Sofia Hayat, Muhammad Irfan, Sajid Asghar, Umer Farooq, Muhammad Adnan Iqbal, Rabia Munir, Kai Bin Liew, Khuriah Abdul Hamid, Sana Shahzad, Muhammad Saleem
+3 more Pervaiz Akhtar Shah, Nyla Ajaz, Syed Haroon Khalid
Cited by: 0
References: 58

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Despite of having broad spectrum anti-bacterial activity, benzimidazole has limited clinical applications out of low solubility and bioavailability. Benzimidazole and cubosomal delivery systems are individually well studied, their combined application remains limited, particularly for newly designed derivatives with unexplored biological activity. OBJECTIVE: This study reports the synthesis and characterization of N-cyclopentyl benzimidazole-loaded cubosomes for antibacterial application through improved solubility and controlled release. METHODS: The N-cyclopentyl benzimidazole was synthesized by the reaction of benzimidazole with Bromo cyclopentane and confirmed by FT-IR, 1H, and 13C NMR spectroscopy. Cubosome nanoparticles were formed by the homogenization method, using glyceryl monooleate (GMO) as a lipid and poloxamer 407 (P407) as a surfactant. Different co-surfactants like Brij 35 (B 35), Myrj 52 (M 52), Tween 20 (T 20), and polyvinyl alcohol (PVA) as stabilizer were used to optimize the formulations and characterized for size, zeta potential, polydispersity index, entrapment efficiency, in-vitro drug release, and transmission electron microscopy. RESULTS: Among the tested formulations, the cubosome containing 3% PVA demonstrated optimal characteristics, including a nanosize (~128 nm), high drug entrapment efficiency (94.08%), and colloidal stability. The antibacterial activity was assessed against Staphylococcus aureus and Escherichia coli. While the free drug exhibited larger zones of inhibition, the cubosome-encapsulated formulation showed sustained antibacterial effects, attributed to improved aqueous dispersion and prolonged release. CONCLUSION: These findings highlight the potential of cubosome-based delivery to enhance the solubility and therapeutic efficacy.

Fields of Study & Subjects

Advancements in Transdermal Drug Delivery Advanced Drug Delivery Systems Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Pakistan Journal of Pharmaceutical Sciences
Volume
39
Issue
5
Pages
1438–1451
Publication date
8 March 2026
Language
EN